Key result
Perceval sutureless AVR yields ~71% eight-year survival with stable gradients and no structural deterioration.
Why the study?
Long-term clinical and echocardiographic outcomes of Perceval sutureless aortic valve implantation, particularly survival, valve-related events, and hemodynamic performance, required evaluation during extended follow-up.
Does Perceval sutureless aortic valve replacement provide favorable long-term survival and hemodynamic outcomes in patients aged 70-85 years?
Cohort (n=150)
No
Does Perceval sutureless aortic valve replacement provide favorable long-term survival and hemodynamic outcomes in patients aged 70-85 years?
Perceval sutureless aortic valve replacement demonstrates favorable long-term survival and sustained hemodynamic performance over an 8-year period in older patients.
Answers are grounded in this paper and cite their sources.
Acceptable long-term Perceval outcomes in elderly patients; leaves open randomized comparisons on durability versus conventional valves.
Background:This study aimed to evaluate the long-term clinical and echocardiographic outcomes of Perceval sutureless aortic valve implantation, with particular emphasis on survival, valve-related events, and hemodynamic performance during extended follow-up.Methods:This retrospective single-center study included 150 consecutive patients aged 70–85 years who underwent Perceval sutureless aortic valve replacement between 2016 and 2025. Of these, 106 patients (70.7%) underwent isolated aortic valve replacement, while 44 (29.3%) underwent additional cardiac procedures. Clinical and echocardiographic data were collected preoperatively, at hospital discharge, and during scheduled long-term follow-up. Overall survival was estimated using Kaplan-Meier analysis.Results:Thirty-day mortality occurred in 5 patients (3.3%), and five patients (3.3%) required permanent pacemaker implantation. Dialysis-requiring acute kidney injury occurred in three patients (2.0%), and stroke or transient ischemic attack occurred in two patients (1.3%). During long-term follow-up (mean 6.1 ± 1.8 years), three patients (2.0%) required valve-related reintervention, primarily due to technical issues or early prosthetic dysfunction. One patient (0.7%) developed moderate-to-severe transvalvular regurgitation during follow-up. The estimated survival rates from the Kaplan–Meier analysis were 90.0% at 1 year, 78.7% at 5 years, and 71.3% at 8 years. The mean transvalvular gradient decreased from 46 ± 11 mmHg preoperatively to 9.8 ± 3.2 mmHg at discharge and remained stable at 11.2 ± 3.9 mmHg at the last follow-up.Conclusion:Perceval sutureless aortic valve implantation demonstrated favorable early clinical outcomes and sustained good hemodynamic performance during long-term follow-up. The low incidence of valve-related reintervention and the absence of structural valve deterioration indicate that this prosthesis is durable and clinically feasible for carefully selected older patients.
No takes yet. Share an insight, caveat, or question.
Khalil et al. (2026) conducted a cohort in Severe aortic stenosis (n=150). Perceval sutureless aortic valve implantation was evaluated on Overall survival at 8 years. Perceval sutureless aortic valve implantation demonstrated an estimated overall survival of 71.3% at 8 years, with stable transvalvular gradients and no structural valve deterioration.
Synapse has enriched 10 related papers. Consider them for comparative context: